About Ribonuclease SLFN12
Ribonuclease SLFN12 (SLFN12) is a protein
from Homo sapiens identified by UniProt accession
Q8IYM2, 578 residues long.
MolForge cross-references it against 0 known binders and
267 disease associations.
Target properties
| Protein name | Ribonuclease SLFN12 |
| UniProt accession | Q8IYM2 |
| Gene | SLFN12 |
| Organism | Homo sapiens |
| Length | 578 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (267)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.50
- neutrophil count · score 0.20
- leukocyte count · score 0.17
- isolated agammaglobulinemia · score 0.08
- platelet count · score 0.08
- lung adenocarcinoma · score 0.08
- familial atrial fibrillation · score 0.07
- Familial short QT syndrome · score 0.07
- Romano-Ward syndrome · score 0.07
- Brugada syndrome · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IYM2-F1 | alphafold | PREDICTED | 82.82 | — |
Amino-acid sequence (578 residues)
MNISVDLETN YAELVLDVGR VTLGENSRKK MKDCKLRKKQ NESVSRAMCA LLNSGGGVIK AEIENEDYSY TKDGIGLDLE NSFSNILLFV PEYLDFMQNG NYFLIFVKSW SLNTSGLRIT TLSSNLYKRD ITSAKVMNAT AALEFLKDMK KTRGRLYLRP ELLAKRPCVD IQEENNMKAL AGVFFDRTEL DRKEKLTFTE STHVEIKNFS TEKLLQRIKE ILPQYVSAFA NTDGGYLFIG LNEDKEIIGF KAEMSDLDDL EREIEKSIRK MPVHHFCMEK KKINYSCKFL GVYDKGSLCG YVCALRVERF CCAVFAKEPD SWHVKDNRVM QLTRKEWIQF MVEAEPKFSS SYEEVISQIN TSLPAPHSWP LLEWQRQRHH CPGLSGRITY TPENLCRKLF LQHEGLKQLI CEEMDSVRKG SLIFSRSWSV DLGLQENHKV LCDALLISQD SPPVLYTFHM VQDEEFKGYS TQTALTLKQK LAKIGGYTKK VCVMTKIFYL SPEGMTSCQY DLRSQVIYPE SYYFTRRKYL LKALFKALKR LKSLRDQFSF AENLYQIIGI DCFQKNDKKM FKSCRRLT
Explore Ribonuclease SLFN12 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets